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Introduction
Obesity is a serious and rising cause of  obstetrical and perinatal morbidity; in developed countries, over 
20% of  women of  childbearing age are defined as being obese (BMI ≥ 30 kg/m2) (1, 2). Obese women are 
about 3 times more likely to develop major complications during pregnancy, such as gestational diabetes or 
preeclampsia, and excess adiposity increases the risk of  preterm birth, which is responsible for ~75% of  the 
4 million neonatal deaths annually worldwide (3, 4); these disorders likely result from placental dysfunction 
(5). Studies using animal models have confirmed a role for obesity in causing placental dysfunction defined 
in part by altered vascular changes within the fetal-maternal environment (6, 7). However, the underlying 
mechanisms linking obesity to poor pregnancy outcomes are unknown.
The condition of  obesity is strongly associated with low-grade chronic inflammation (8). Studies 
using rodent models show that obesity-related stress alters immune cell polarization in metabolically 
active organs such as adipose tissue, pancreas, and liver (9–11). For example, recent work has highlighted 
the importance of  immunomodulatory factors (i.e., type-2 cytokines) produced by immune cells for 
maintaining healthy metabolic homeostasis in adipocytes (12–14). In the condition of  obesity, adipose-
derived stress signals recruit and activate local immune sentinels, such as NK cells and cytotoxic CD8+ 
T cells, which in turn produce proinflammatory factors that polarize adipose tissue resident macro-
phages towards a classical M1-like phenotype (9). The long-term chronicity of  these proinflammatory 
signals leads to increases of  proinflammatory cytokines in the blood that impact immune cell function(s) 
at distal organ sites; effects on glucose intolerance, insulin resistance, and the development of  type 2 
diabetes are well-accepted examples of  this (15). However, the impact of  obesity-related chronic inflam-
mation on maternal uterine immune cell composition and function remains unexplored.
Resident NK cells of  the uterus, herein referred to as uterine natural killer (uNK) cells, represent as 
much as 60%–70% of  uterine leukocytes in early pregnancy (16, 17). Unlike conventional cytotoxic NK 
cells, uNK cells play central roles in controlling neoangiogenesis, uterine artery remodeling, placental devel-
opment, and the immune response against fetal antigen (16–18). Studies in mice highlight the importance 
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of  uNK cells in pregnancy, where genetic ablation (19, 20) or functional inactivation (21) of  uNK cell sub-
sets results in profound defects in decidual bed arterial remodeling and impaired angiogenesis. In particu-
lar, uNK cell interactions with fetal-derived trophoblasts are important for appropriate uNK cell activation 
(22, 23), resulting in the subsequent secretion of  proinflammatory cytokines (IFN-γ, TNF-α, and angio-
kines [placental growth factor and VEGF-A and -C]) (21, 24). These secreted factors help direct uterine 
blood vessel transformation from narrow-bore vessels under strict vasomotor control to high-capacity/low-
pressure conduits lacking encapsulating smooth muscle. Inappropriate or insufficient uNK cell activation 
is associated with impaired blood vessel transformation and reduced nutrient and gaseous delivery to the 
placenta and developing fetus (16). Not surprisingly, these physiological inadequacies are strongly associ-
ated with life-threatening disorders of  pregnancy, including recurrent miscarriage (25), preeclampsia (26), 
and fetal growth restriction (27). Thus, the importance of  uNK cells in establishing a healthy maternal-fetal 
interface cannot be overstated.
Here we examine the effect of  maternal obesity on uNK cell biology. We show that maternal obesity 
leads to reductions in uNK cell numbers within uterine mucosa, and these changes correlate with impaired 
vascular remodeling. Using a global gene expression platform, we show that uNK cell expression signa-
tures from obese women are distinct from those of  lean women. Namely, uNK cell gene signatures from 
obese women show enrichment of  genes linked with aberrant extracellular matrix (ECM) production and 
growth factor signaling resembling fibrogenesis. Functional studies highlight PDGFR signaling as a key 
pathway dysregulated in uNK cells in obese pregnancies, where its activity drives the expression of  fibril-
lar COL3A1 (collagen, type-3, alpha 1) and DCN (decorin). Lastly, we establish that decorin, identified as a 
gene highly enriched in uNK cells from obese pregnancies, strongly impacts trophoblast health, resulting 
in placental impairment.
Results
Maternal obesity is tightly linked with systemic inflammation and uNK cell impairment. To examine the effects of  
maternal obesity on uNK cell biology, a cohort of  women 19–35 years of  age undergoing elective preg-
nancy terminations between 6 and 13 weeks of  gestation was established and characterized. From all con-
senting women, blood, uterine (decidual mucosa), and placental tissues were collected and processed for 
biochemical and cellular assays. Women were clinically characterized (weight and height, and self-reported 
variables including exposure to cigarette smoke, diabetes, prescribed antiinflammatory or antihypertensive 
medications) and categorized into two groups: obese (BMI ≥ 30 kg/m2, n = 45) or control (BMI 20–24.9 
kg/m2, n = 45) subjects (Table 1 and Supplemental Table 1; supplemental material available online with 
this article; doi:10.1172/jci.insight.85560DS1). As obesity is associated with low-grade systemic inflam-
mation, we set out to confirm that this connection also holds true for obese women in early pregnancy. 
ELISA measurements of  serum C-reactive protein (CRP; an acute-phase reactant factor of  hepatic origin) 
and the proinflammatory adipokine leptin (synthesized predominately by adipocytes), showed significant 
positive relationships with increasing BMI (CRP: r2 = 0.46, P < 0.0001; leptin: r2 = 0.57, P < 0.0001) (Table 
1 and Figure 1, A and B). Using a threshold for CRP that differentiates chronic low-grade inflammation 
from acute inflammation and predicts patients’ risk in developing heart disease (≥ 3.0 μg/ml) (28, 29), 
we observed that 75.5% of  obese women (34 of  45) showed CRP levels indicative of  systemic low-grade 
inflammation (Figure 1, A and C). In contrast, only 13.3% (6 of  45) of  control subjects had CRP levels 
above this threshold (Figure 1, A and C). The linear correlation between serum CRP and leptin was strong 
(r2 = 0.35), indicating that the increase in low-grade inflammation measured in obese pregnant women 
likely stems from increased adiposity (Figure 1D).
Table 1.  Characteristics of sample cohort
Age (Year) Week of Gestation BMI (kg/m2) CRP median (μg/ml) CRP IQR Leptin median  
(ng/ml)
Leptin IQR
Control (n = 45) 25 8.6 21.7 0.9 0.6 to 2.0 10,363 7,013 to 15,652
Obese (n = 45) 28 8.9 35.0 6.3 P < 0.0001 2.9 to 8.9 39,810 P < 0.0001 29,283 to 53,006
Abbreviations: CRP, C-reactive protein; IQR, interquartile range. 
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CD56bright NK cells are the predominant uterine immune cell in pregnancy, playing important roles in 
orchestrating spiral artery remodeling, angiogenesis, and placental development (16). Because obesity is linked 
to altered production of immunomodulatory factors known to affect immune cell function (15), we set out to 
determine if  decidual CD56bright uNK cells are altered in pregnancies of obese women. Using a multicolor flow 
cytometry strategy, uNK cell proportions from gestationally age-grouped (7–10 weeks) control and obese sub-
jects were measured (Figure 2A). As expected, uNK cells were the predominant immune cell in control decidua, 
comprising 68.2% of CD45+ decidual leukocytes (median = 68.2%, interquartile range [IQR] = 64.6 to 76.0) 
(Figure 2B). In these tissues, a small proportion (~5%) of immune cells were CD3–/CD56dim/CD16+ NK cells, 
most likely originating from contaminating maternal blood; proportions of CD56dim/CD16+ NK cells did not 
differ between control and obese women (Supplemental Figure 1A). We did, however, observe a reduction in 
the proportion of uNK cells in obese subjects compared to controls (obese median = 58.9%, IQR = 48.4 to 70.1, 
P =0.03) (Figure 2, B and C). CD56 median fluorescence intensity (MFI) within the CD56bright NK population 
did not differ between control and obese groups, suggesting that CD56 surface expression is not altered (Supple-
mental Figure 1, B and C). A possible explanation for the proportional decrease in uNK cells may be related 
to alterations in cell proliferation. To examine this possibility, we measured proportions of Ki67+ uNK cells in 
control and obese subjects by flow cytometry and found that proportions of proliferating uNK cells did not dif-
fer between BMI groups (Supplemental Figure 1, D and E). In line with our finding showing that high BMI is 
associated with reduced proportions of uNK cells, we also observed that CD56bright cell proportions inversely cor-
relate with serum leptin levels (r2 = 0.33, P = 0.0005) (Supplemental Figure 1F). This relationship held true for 
CRP; however, the association was modest and not significant (r2 = 0.11, P = 0.06) (Supplemental Figure 1G). 
Together, these findings indicate that obesity-linked inflammation in early pregnancy alters uNK cell balance.
To determine if  the decreased proportion of  uNK cells in obese women is due to absolute reductions in 
cell numbers, NK cells from decidual tissues at 11–13 weeks of  gestation were quantified by immunofluo-
Figure 1. Maternal obesity is associated with low-grade chronic inflammation. (A) Relationship between serum 
C-reactive protein (CRP) and BMI shown graphically as a line amongst 90 women in early pregnancy. The horizontal 
line indicates the CRP threshold (3 μg/ml), indicative of low-grade inflammation. The blue hashed box indicates 
control (lean) BMI samples having CRP values < 3 μg/ml; the red hashed box indicates obese BMI samples having 
CRP values ≥ 3 μg/ml. r2 = the coefficient of determination. (B) Relationship between serum leptin and BMI shown 
graphically as a line. (C) Pie chart depicting proportions of control and obese BMI women presenting with/without 
elevated serum CRP. (D) Linear regression analysis showing the relationship between serum CRP and leptin between 
control and obese BMI women. Shown are the 95% confidence interval (95% CI) and the coefficient of determination 
(r2). P < 0.0001, linear regression statistics.
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rescence (IF) microscopy. For these analyses, the older gestational age range was selected, as it allows us 
to quantify uNK cell numbers concurrently with physiological changes in uterine arteries; uterine vascular 
changes at earlier time points in pregnancy are not as robustly evident. Dual-immunolabeling strategies 
targeting NK cells (CD56), smooth muscle cells (smooth muscle actin [SMA]), and endothelial cells (CD31) 
were performed. Consistent with our flow cytometry data, abundant uNK cells were observed in the decidual 
Figure 2. Maternal obesity is linked 
with reduced numbers of uterine 
NK (uNK) cells and delayed artery 
remodeling. (A) Flow cytometry gat-
ing strategy to identify and quan-
tify uNK cells in control and obese 
women. Live decidual leukocytes 
were selected by excluding nonviable 
cells and CD3+ lymphocytes. uNK cell 
proportions within the CD45+ frac-
tion were quantified by their surface 
expression of CD56 and CD16 and are 
presented as proportion of cells. SSC, 
side scatter. (B) Representative flow 
cytometry plots of uNK cell propor-
tions in control (n = 16) and obese (n = 
16) women. Median values of CD56bright 
cells are shown within plots. IQR, 
interquartile range. (C) Scatter plots 
depicting CD56bright cell proportions in 
control and obese women; horizon-
tal line indicates group median. (D) 
Representative immunofluorescence 
images of first trimester decidual 
tissue (11–13 weeks of gestation) 
from control (n = 10) and obese (n 
= 10) women immunostained with 
antibodies directed against CD56 
(green), smooth muscle actin (SMA; 
red), and CD31 (red); DAPI-stained 
nuclei are labeled blue. Scale bars: 
50 μm. The perforated white box 
indicates enlarged image. Quantifica-
tion of (E) absolute uNK cell numbers, 
(F) arterial smooth muscle thickness, 
(G) arterial vessel:lumen ratios and 
(H) numbers of small (< 100-μm 
diameter) and large (≥ 100-μm 
diameter) arteries per field of view 
from decidual specimens of control 
(C) and obese (O) women. Represen-
tative immunofluorescence images 
(I) and quantification of propor-
tions of apoptosing uNK cells (J) in 
decidual tissue from control (n = 10) 
and obese (n = 10) women. Sections 
were immunostained with antibod-
ies directed against CD56 (red) and 
cleaved caspase-3 (cl-CASP3; green); 
DAPI-stained nuclei are labeled blue. 
White arrowheads highlight apoptos-
ing uNK cells. Scale bars: 50 μm. 
Statistical analyses were performed 
using a nonparametric 2-tailed Mann-
Whitney t test.
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mucosa of  control subjects (Figure 2D). In these tissues, NK cells preferentially formed large cellular aggre-
gates proximal to remodeled uterine arteries (Figure 2D). Importantly, arterial remodeling in control tissue 
was extensive, as shown by thin discontinuous SMA/CD31 signals surrounding arterial lumens directly 
adjacent to large clusters of  NK cells (Figure 2D). In contrast with this, uNK cells from obese women were 
fewer in number (Figure 2, D and E), showed increased thickening of  smooth muscle around arteries (Figure 
2F), had increased vessel-to-lumen ratios (Figure 2G), and harbored fewer large-bore arteries (all surrogate 
measurements of  reduced vascular remodeling) (Figure 2H). Of note, total artery numbers (both small and 
large) did not differ between BMI groups, suggesting that overall vascularity may not be affected (Figure 
2H). To examine if  uNK cell survival is altered in obesity, dual IF labeling of  CD56 in combination with 
cleaved caspase-3 antibody highlighted that uNK cell apoptosis is elevated in obese women (Figure 2, I and 
J). Taken together, these findings indicate that uNK cell-directed uterine arterial remodeling is impaired in 
obese women in early pregnancy, potentially arising from reduced numbers of  uNK cells within decidual 
tissues; decreased uNK cell numbers may be due to heightened apoptosis.
Maternal obesity generates a unique uNK cell gene expression fingerprint. Our finding that maternal obesity 
results in reduced numbers of  uNK cells and under-remodeled uterine arteries suggests a possible defect in 
NK cell differentiation and/or activation. To examine the full spectrum of  possible gene pathway altera-
tions, microarray gene expression profiles were generated from negatively selected immunomagnetic bead–
purified uNK cells from control and obese women (Supplemental Table 2). Decidual leukocyte enrichment 
via density-gradient centrifugation directly followed by NK cell negative selection and CD16 positive exclu-
sion routinely yielded CD56bright uNK cell purities near 95% (Figure 3A, Supplemental Figure 2, A and B, 
and Supplemental Table 2). Unsupervised hierarchical clustering and principal component analysis (PCA) 
of  adjusted global gene expression profiles did not segregate the 13 control uNK cell gene signatures from 
the 11 obese uNK cell signatures, likely reflecting the inter- and intraheterogeneity in our human cohort 
(Supplemental Figure 2C). This finding prompted us to investigate the expression difference of  a subset of  
genes between uNK cells from control and obese subjects. Hierarchical clustering of  the top-ranked 100 
or 200 high-variance probes across all samples (ordered by their coefficient of  variance [CV]) separated 
control and obese uNK cell gene signatures with 75% accuracy (Supplemental Figure 2D). Using the 200 
high-CV probe signature, 4 distinct sample clusters were identified (Groups 1 to 4) as shown by the cluster 
dendrogram (Figure 3B). Groups 1 and 2 (G1/2) showed strong enrichment of  obese uNK cell samples (9 
of  13), whereas Groups 3 and 4 (G3/4) showed enrichment for control BMI samples (9 of  11). Notably, 
strong concordance with serum CRP levels was observed, underscored by the alignment of  2 control sam-
ples (D202 and D274) having elevated CRP with G2 obese samples (Figure 3B). The 200 high-CV probe 
signature aligned 2 outlier obese samples (D181 and D210) with the control G4 group and 2 control sam-
ples (D184 and D190) with the G1 group; sample clustering is graphically illustrated by PCA (Figure 3C). 
Additionally, hierarchical gene clustering of  the 200 high-CV probes identified 11 gene groups (Figure 3B 
and Supplemental Figure 2E). Gene cluster 3 (C3) was the dominant cluster that consisted of  155 probes 
primarily upregulated in CD56bright NK cells from obese subjects. Gene ontology (GO) pathway analysis 
of  C3 genes using ToppGene software (30, 31) (5% FDR threshold) showed enrichment of  molecular 
functions, biological processes and gene pathways centered on ECM organization, collagen biosynthesis/
assembly, and growth factor binding (Figure 3D and Supplemental Table 3). Interestingly, the C3 gene sig-
nature also showed enrichment of  genes associated with pregnancy/fertility disorders such as spontaneous 
abortion and endometriosis (Figure 3D); this association is in accordance with the known elevated risk of  
developing these disorders with increasing BMI (32).
Figure 3. Maternal obesity instructs gene expression-informed uterine NK (uNK) cell clustering. (A) Schema of experimental pipeline starting from 
NK cell purification, RNA extraction, microarray hybridization, data preprocessing, and computational analyses. (B) Dendrogram depicts hierarchical 
clustering of control and obese uNK cell samples generated by the 200 high coefficient of variation (high-CV) gene signature where the 24 samples (n 
= 13 control; n = 11 obese) were separated into 4 groups (G1, G2, G3, and G4). The heatmap displays expression profiles of the top 200 genes with high-
est CV; the 200 high-CV genes are clustered into 11 gene clusters depicted by different colored bars (C1–C11). Within the heatmap, blue = low expres-
sion; black = mid-level expression; yellow = high expression. For each sample, patient BMI and C-reactive protein (CRP) status is indicated above the 
heatmap (control = black; obese = green; low CRP = white; high CRP = red). (C) Principal component analysis (PCA) of top 200 high-CV genes across 
24 uNK cell samples. Control samples are indicated by black type while obese samples are indicated by green. (D) Dotmap depiction of significant 
pathways enriched in the 154 C3 probe signature determined by ToppGene analyses. FDR values (q value; Bonferroni) are represented by the color of 
boxes, and percentage of genes in the GO annotated list are indicated by the size of the circle within each box. Statistical analyses were performed in 
the R statistical environment using limma library beadarray packages. ECM, extracellular matrix.
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Figure 4. Differential gene expression (DE) between uterine NK (uNK) cell control- and obese-enriched groups. (A) Volcano plot of differential mRNA 
levels averaged between G1/G2 and G3/G4 sample groups. x axis: coefficients from linear model in log2 scale; y axis: P values adjusted for multiple testing. 
Black circles indicate probes with an FDR ≥ 0.001; orange and red circles indicate probes with an FDR < 0.001; red circles indicate probe overlap with high 
coefficient of variation (high-CV) probes. (B) Hierarchical clustering of uNK cell samples from obese and control subjects informed by the DE signature 
(FDR < 0.001) comparing G1/G2 and G3/G4 groups. For each sample, patient BMI and C-reactive protein (CRP) status is indicated above the heatmap (con-
trol = black; obese = green; low CRP = white; high CRP = red). (C) Venn diagram showing the number of genes shared between the 200 high-CV list and DE 
upregulated and downregulated genes (FDR < 0.001). (D) Dotmap depiction of significant pathways enriched in the 885 DE gene signature determined by 
ToppGene. FDR values (q value, Bonferroni) are represented by box color, and percentage of genes in the GO annotated list are indicated by circle size. ECM, 
extracellular matrix. (E) qPCR analysis of PDGFRA, PDGFRB, COL1A1, and DCN in G1/G2 and G3/G4 groups. GAPDH was used for normalization. Individual 
sample values are indicated by color: black = control/low CRP; red with black = control/high CRP; green = obese/high CRP. Statistical analyses for DE were 
performed in the R statistical environment; qPCR statistical analyses were performed using a nonparametric 2-tailed Mann-Whitney t test.
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Differential gene expression analysis identifies uNK cell gene pathways altered in obesity. To identify and fur-
ther define gene networks associated with maternal obesity, we performed a differential gene expression 
analysis between control-enriched (G3/4) and obese-enriched (G1/2) groups. This analysis identified 1,024 
differentially expressed probes (885 genes; FDR < 0.001) (Supplemental Table 4). Visualization of  these 
data by volcano plot clearly shows that the majority of  differentially expressed genes are overexpressed in 
the obese-enriched group (698 of  885 genes), and that the differentially expressed genes showing the great-
est log2-fold change align strongly with the 200 high-CV gene signature (Figure 4A). Sample hierarchical 
clustering using the 1,024-probe signature again identified two major groups; one group showed overrepre-
sentation of  control uNK cell genes (9 of  11), while the other group showed enrichment for gene signatures 
derived from uNK cells isolated from predominantly obese subjects (9 of  13; Figure 4B). Notably, high 
overlap between high-CV and differentially expressed genes was observed, where 127 high-CV genes over-
lapped with differentially overexpressed genes (Figure 4C). Genes common to both these gene sets included 
multiple fibrillar collagens (COL1A1, COL1A2, COL3A1, COL4A5, COL5A1, COL5A2, COL6A1, COL6A2, 
and COL6A3), insulin-like growth factor binding proteins (IGFBP4, IGFBP5, and IGFBP6), tissue inhibitors 
of  metalloproteinases (TIMP1, TIMP2, and TIMP3), aldehyde dehydrogenases (ALDH1A1, ALDH1A2, and 
ALDH1A3), and PDGFRs (PDGFRA and PDGFRB) (Supplemental Table 5). Also common to both the 
high-CV and differentially expressed gene sets was the gene DCN, encoding for the small leucine-rich pro-
teoglycan decorin, which has previously been shown to modulate collagen organization, inhibit trophoblast 
migration and growth, and is frequently upregulated in proinflammatory fibrotic conditions (33–35).
In addition to BMI as a predictive variable, serum CRP levels were robust in instructing sample cluster-
ing. Notably, the clustering of  2 control samples harboring elevated CRP (D274 and D202) with 9 obese 
samples (all characterized with ≥ 3.0 μg/ml serum CRP) underlined this interaction, whereas only 2 obese 
uNK cell signatures having elevated CRP clustered with the control G3/G4 group (Figure 4B). Sample 
segregation informed by serum CRP suggests that systemic inflammation is a key variable in driving altered 
uNK cell gene expression.
GO analysis of  the 885 differentially expressed genes (FDR < 0.001) using ToppGene identified enrich-
ment of  molecular pathways and biological processes central to growth factor binding, cell adhesion/integ-
rin biology, cell migration/motility, vascular development, PDGFR signaling, and enzymatic activity (Bon-
ferroni q value < 0.05; Figure 4D and Supplemental Table 6). Consistent with pathways enriched in the C3 
gene cluster, the 885 differentially expressed genes also showed enrichment for biological pathways linked 
to ECM organization and collagen biosynthesis (Figure 4D and Supplemental Table 6). Real-time PCR 
(qPCR) analysis of  4 selected genes (COL1A1, DCN, PDGFRA, and PDGFRB) confirmed their overexpres-
sion in obese-enriched uNK samples (Figure 4E). Notably, 1 obese uNK cell sample (D92) and the 2 outlier 
control uNK cell samples harboring high CRP (D274 and D202) consistently showed marked increases in 
mRNA levels of  the 4 genes tested, while expression levels of  these genes in samples from the control G3/
G4 group was consistently low (Figure 4E). The ToppGene GO pathway findings, supported in part by 
the overexpression of  specific matrix-associated genes known to be elevated in fibrotic and inflammatory 
conditions (i.e., DCN, COL1A1, and ACTA2) (36), suggest that an altered in utero environment, driven in 
part by dysregulated decidual NK cell function/activation, is common in pregnancies of  obese women.
PDGFR hyperactivity induces survival signals, but does not affect uNK cell activation. The above gene expres-
sion and GO pathway analyses identified PDGFR signaling as a key pathway altered in uNK cells from 
obese pregnant women. Since the significance of  PDGFR signaling in NK biology is poorly defined, we 
next set out to confirm whether uNK cells from obese women express elevated PDGFR protein levels and 
whether heightened PDGFR activity affects uNK cellular functions. IF microscopy and flow cytometric 
analysis confirmed PDGFR localization to NK cells in uterine tissues of  both control and obese subjects 
(Figure 5A and Supplemental Figure 3, A and B). Notably, uNK cell PDGFR-α IF staining in tissue sec-
tions of  obese samples was more frequently observed and showed greater staining intensity (Figure 5A). 
While proportions of  CD56bright uNK cells expressing PDGFR-β did not differ between control (n = 6) and 
obese (n = 6) samples (Supplemental Figure 3B), PDGFR-β MFI was modestly higher in the obese group 
(Figure 5B and Supplemental Figure 3C); this finding is consistent with PDGFR’s overexpression at the 
mRNA level in the majority of  uNK cells isolated from obese women. To confirm that PDGFR is function-
al in uNK cells, we stimulated immunomagnetic bead–purified uNK cells from control (n = 3) and obese 
(n = 3) women with PDGF-BB (a PDGFR ligand capable of  activating both α- and β-type PDGFRs), and 
examined activation of  canonical PDGFR pathways via immunoblotting. PDGF-BB treatment resulted in 
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activation of  PDGFR-α in uNK cells from both control and obese subjects, as shown by phosphorylation 
of  PDGFR-α’s Tyr 849 residue (Figure 5, C and D; full, uncut gels available in Supplemental Figure 4). 
Notably, both total and phosphorylated PDGFR-α levels were higher in uNK cells from obese women 
(Figure 5D). Consistent with an increase in PDGFR activity, PDGF-BB stimulation also led to profound 
induction of  phospho-Akt (Ser 473) and phospho-Erk1/2 (Thr 202/204) in the 3 uNK cells examined from 
obese subjects, while pathway induction was less pronounced in control cells (Figure 5, C and D). Together, 
these analyses demonstrate that PDGFR signaling is intact and elevated in uNK cells of  obese women.
The effect of  PDGFR activation on key uNK cell functional readouts was next examined. We spe-
cifically measured the ability of  PDGF-BB to induce uNK cell cytokine production (TNF-α and IFN-γ), 
degranulation/cytotoxicity (measured via CD107a surface expression), and migration (Supplemental Fig-
ure 3D). Intracellular expression of  TNF-α and IFN-γ in PDGF-BB–treated uNK cells, as measured by 
flow cytometry, did not differ from levels in untreated controls (Figure 5, E–G). In these experiments, uNK 
cells from only obese subjects were used, as levels of  PDGFR were expected to be higher than in control 
subjects and the uNK cells were therefore expected to be more sensitive to PDGF treatment; PMA/iono-
mycin treatment served as a positive control. Cytokine levels in uNK cells cocultured with K562 target 
cells were higher than in unstimulated baseline conditions; however, PDGF-BB treatment neither potenti-
ated nor inhibited this induction (Figure 5, E–G). uNK cell degranulation/activation measured by the 
cell-surface marker CD107a in cells cocultured with K562 target cells was also not affected by PDGF-BB 
treatment (Figure 5H).
In other cell systems (i.e., in cancer and smooth muscle), PDGF promotes cell migration (37, 38). Since 
NK cell infiltration from peripheral blood into the uterus is thought to be a major source of  uNK cells in 
pregnancy, we examined if  PDGFR signaling could induce uNK cell motility using a Transwell system. 
Surprisingly, PDGF-BB, serving as a chemoattractant, had no effect on the migration of  uNK cells isolated 
from either control (n = 3) or obese (n = 3) women; however, fetal bovine serum serving as a positive con-
trol did promote uNK cell migration (Figure 5I). The results of  these experiments suggest that PDGFR 
signaling does not affect typical NK cellular readouts such as proinflammatory cytokine production or 
cytotoxicity, but may promote cell survival as shown by enhanced Akt and Erk1/2 activity.
PDGFR signaling drives expression of  ECM genes in uNK cells. Our microarray-informed finding that uNK 
cells from obese women are more likely to overexpress COL1A1 as well as other fibrillar collagens and ECM-
associated genes was unexpected. Upregulation of  ECM and fibrous connective tissue genes is strongly 
associated with chronic inflammation and fibrotic-like conditions in the liver and lung (36). To investigate 
the potential contribution of  aberrant collagen deposition by uNK cells within the uterine mucosa of  obese 
women (uNK cells comprise ~30% of  all decidual cells in early pregnancy), dual IF microscopy was per-
formed probing for CD56 (NK cell marker) and alpha-1 type I collagen (collagen-I). Collagen-I was broadly 
localized throughout decidual tissues of  both BMI groups, forming network-like structures proximal to and 
surrounding decidualized stromal cells (Figure 6A). Collagen-I also showed woven-like patterns around 
unremodeled uterine blood vessels that appeared compact and dense (Figure 6A). Within and proximal to 
uNK cells, collagen-I colocalization was nearly absent in tissues from controls; however, diffuse expression 
of  collagen-I was frequently observed amongst uNK cells in obese subjects, suggesting that uNK cells in 
obesity are actively contributing to collagen matrix deposition (Figure 6A).
In tissue fibroblasts and vascular smooth muscle cells, fibrillar collagen overexpression is in part reg-
Figure 5. PDGFR induces survival signals in uterine NK (uNK) cells but does not alter cytokine expression, cytotoxicity, or migration. (A) Repre-
sentative images of decidual tissues at 11–13 weeks of gestation from control (n = 10) and obese (n = 10) women immunostained for CD56 (red) and 
PDGFR-α (green). Nuclei are labeled with DAPI (blue). Scale bars: 50 μm. (B) Representative flow cytometry histogram showing PDGFR-β cell-surface 
intensity on uNK cells from control or obese women. The median fluorescence intensity (MFI) ± SEM between control (n = 6) and obese (n = 6) uNK 
cells is shown above plot: solid color indicates the fluorescence minus one baseline signal. Immunoblots (C) and densitometric quantification (D) 
depicting activation of PDGFR-α, Erk1/2, and Akt after 10 minutes of stimulation with 100 ng/ml PDGF-BB (BB; a PDGFR ligand capable of activating 
both α- and β-type PDGFRs) in control (n = 3) and obese (n = 3) uNK cells. Molecular weights (kDa) are shown to the left and β-actin indicates loading 
control. (E) Representative flow cytometry plots of intracellular IFN-γ and TNF-α, as well as surface expression of CD107a in 1 × 106 CD56+ uNK cells 
either untreated (–) or treated with 30 ng/ml PDGF-BB for 5 hours in the presence or absence of K562 target cells (effector/target ratio 2:1). UC = 
untreated control. Proportion (%) of CD56+ uNK cells showing positivity for these makers is indicated within plots. Scatter plots show proportional 
levels of CD56+ uNK cell (n = 6) (F) IFN-γ, (G) TNF-α, and (H) CD107a. (I) Line graphs indicate fold-change (FC) differences in migration of 2 × 105 uNK 
cells treated or untreated with PDGF-BB over 3 hours. uNK cells were purified from control (black, n = 3) or obese (green, n = 3) subjects. FBS treat-
ment served as a positive control. Results are presented as scatter plots with indicated median and interquartile range. Statistical analyses between 
groups were performed using a nonparametric 2-tailed Mann-Whitney t test. NS, not significant; PMA, phorbol 12-myristate 13-acetate.
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ulated by PDGFR signaling (39). Our finding that PDGFRA and PDGFRB gene levels and signaling path-
ways are intact and hyperactive in obese uNK cells prompted us to examine if  PDGFR regulates expression 
of  collagens and collagen-associated genes. Isolated uNK cells from obese subjects were stimulated with or 
without 30 ng/ml PDGF-BB for 12 hours, after which mRNA levels of  4 collagen and collagen-associated 
ECM genes previously shown to be overexpressed in the obese G1/G2 group (COL1A1, COL3A1, COL6A3, 
and DCN) were measured by qPCR analysis. PDGF-BB treatment did not affect COL1A1 or COL6A3 lev-
els, although stimulation did increase the expression of  COL3A1 and DCN by approximately 3.0-fold over 
untreated levels (Figure 6B). IF microscopy within decidual tissues of  control samples showed decorin 
localization proximal to stromal cells, with low signal surrounding uNK cells (Figure 6C). In contrast, 
abundant decorin signal was seen proximal to uNK cells in obese women (Figure 6C), where the mean 
uNK-derived decorin signal was higher than in control uNK cells. Together, these findings provide evi-
dence that elevated PDGFR signaling in uNK cells of  obese pregnant women may be in part responsible 
for the increased production (COL3A1) and/or remodeling (via DCN) of  fibrillar collagen within the fetal-
maternal interface.
Decorin blocks placental trophoblast outgrowth. DCN was shown to be one of  the highest rank-ordered genes 
overexpressed in the obese G1/G2 uNK cell cohort (Supplemental Table 4). Furthermore, our finding that 
DCN mRNA levels in uNK cells are controlled via PDGFR establishes a possible mechanism whereby 
decorin levels are regulated in obesity. uNK cells not only play critical roles in pregnancy by promoting 
Figure 6. PDGF controls expression of collagen-associated genes in uterine NK (uNK) cells. (A) Representative images 
of decidual tissues at 11–13 weeks of gestation from control (n = 10) and obese (n = 10) women immunostained for CD56 
(red) and collagen-1 (white). Nuclei are labeled with DAPI (blue). The perforated white box indicates the enlarged image. 
(B) qPCR analysis of COL1A1, COL3A1, COL6A3, and DCN in 1 × 106 uNK cells treated or untreated (–) with 30 ng/ml 
PDGF-BB (BB; a PDGFR ligand capable of activating both α- and β-type PDGFRs) for 12 hours. Gene expression experi-
ments were performed in triplicate and repeated on uNK cells isolated from 3 distinct decidual leukocyte preparations 
(n = 3). Data presented as the mean ± SD and statistical analyses were performed using 2-tailed Wilcoxon signed-rank t 
tests. (C) Representative immunofluorescence images of decidual tissues at 11–13 weeks of gestation from control and 
obese women immunostained with antibodies directed against CD56 (red) and decorin (white). Scale bars: 25 μm. (D) 
Scatter plots show decorin mean channel intensities in uNK cells from control (n = 10) and obese (n = 10) women; IgG1 
staining in 4 obese tissues establishes background signal. Horizontal lines indicate group median. Statistical analyses 
between groups were performed using a nonparametric 2-tailed Mann-Whitney t test.
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remodeling of  uterine arteries, but also control trophoblast survival and invasion (17). The effects of  deco-
rin production within the maternal-fetal interface is not well described; however, studies investigating its 
effects on trophoblastic in vitro models suggest that decorin negatively regulates cell proliferation and inva-
sion (34). We therefore set out to examine the effects of  uNK cell–derived decorin on trophoblast column 
growth using a first trimester placenta ex vivo culture system; cellular processes central to trophoblast 
column formation are critical for successful placental development and pregnancy. For these experiments, 
uNK cell conditioned media (CM) was harvested from uNK cells isolated from 3 obese women cultured 
over 18 hours; uNK cell purity was routinely greater than 90% showing less than 3% CD45– cell contamina-
tion (Figure 7A). Immunoblotting showed that uNK cells express a high molecular weight decorin in CM, 
indicative of  varying levels of  glycosylation (Figure 7B; full, uncut gels available in Supplemental Figure 
4). Matrigel-imbedded placental explants cultured in control medium showed extensive trophoblast column 
outgrowth over 48 hours (Figure 7, C–E). In contrast, placental explants cultured in uNK cell CM exhib-
ited impaired column outgrowth (Figure 7, D and E). Importantly, the inhibitory effect of  uNK cell CM 
on column outgrowth was partially reversed by cotreatment with a function-neutralizing decorin antibody, 
suggesting that uNK cell–derived decorin impairs placental column formation (Figure 7, D and E).
To examine the direct effect of  decorin on placental explant outgrowth, explants were cultured in 
the presence or absence of  recombinant decorin. Ectopic decorin strongly inhibited trophoblast column 
outgrowth and cell invasion into surrounding matrix; in untreated control explants, trophoblast column 
growth and invasion were prominent (Figure 7, F and G). Since column outgrowth is regulated in part 
by trophoblast proliferation and survival, we examined the effect of  decorin on these 2 cellular processes. 
Recombinant decorin did not alter trophoblast proliferation within intact cellular columns as measured 
by Ki67 positivity within keratin-7+ cells (Figure 7, H and I). However, decorin treatment led to profound 
increases in caspase-cleaved keratin-18 signal (a readout of  cell apoptosis) in proliferating trophoblasts 
localized to cell columns and to senescent trophoblasts invading through Matrigel matrix (Figure 7, H 
and J). Taken together, these results suggest that decorin overexpression within the maternal-fetal inter-
face affects placental development and health by inhibiting trophoblast column formation via mecha-
nisms promoting cell apoptosis. Our data indicate that decorin overexpression by uNK cells in obesity 
may play a central role in impairing placental health.
Discussion
We have shown that maternal obesity instructs alterations in uNK cell composition and global gene expres-
sion within the uterine environment in early pregnancy. Notably, obesity leads to reductions in uNK cells 
within the decidual mucosa, and these cellular changes are tightly linked with impaired remodeling of  uterine 
vasculature. Global gene expression strategies highlight the broad enrichment of  ECM-signaling and growth 
factor–signaling pathways in uNK cells from obese pregnancies that mirror fibrotic and inflammatory signals 
associated with chronic tissue damage. Specifically, we provide evidence that hyperactive PDGFR signaling 
induces uNK cell survival signals and drives expression of  COL3A1 and DCN. Importantly, our study identifies 
an obesity-driven mechanism imparted by uNK cell overexpression of  decorin in controlling placental devel-
opment and health. To our knowledge, this is the first study to establish mechanistic insight into the effects of  
obesity on uterine immune cell function and establishment of  the maternal-fetal interface in humans.
Figure 7. Decorin inhibits placental column outgrowth. (A) Representative flow cytometry plots showing uterine NK (uNK) cell purity following 18 hours of 
culture. (B) Immunoblot showing decorin in uNK cell conditioned media (CM) from 3 distinct obese uNK cell cultures. Decidual tissue (Decidua) and control 
media (RPMI) function as positive and negative controls, respectively. Molecular weights (kDa) are shown to the left. (C) A schematic representation of the 
experimental procedure and timeline: CM = conditioned medium; DCN Ab = decorin-neutralizing antibody; d = day. (D) Quantification of extravillous tro-
phoblast (EVT) column outgrowth in control (Con) and uNK cell CM–treated (uNK CM) placental explants in the presence or absence of a decorin-blocking 
antibody (DCN Ab). Outgrowth is calculated as the difference in column length (μm) at 48 and 0 hours. Explant assays were performed in duplicate using 
placental villi from 3 independent placentae (n = 12 to 14 columns per condition). (E) Representative images of placental villous explants cultured in control 
media, or in uNK CM with/without DCN Ab at 0 and 48 hours of culture. Inverted images of explants (invert) provide better contrast, where “villi” indicates 
placental villi, and hashed lines represent the EVT column base (white) and invasive extremity (black). Scale bars: 100 μm. Quantification (F) and represen-
tative images (G) of EVT column outgrowth following treatment with (n = 10 columns) or without (n = 10 columns) 20 μg/ml recombinant decorin (DCN). 
Placental explants were established from 4 independent placentae. (H) Representative images showing proliferative (Ki67+; red) and apoptotic (caspase-
cleaved cytokeratin-18+ [K18+]; green) trophoblasts within EVT columns. The trophoblast marker keratin-7 (K7) is labeled white and nuclei are stained with 
DAPI (blue). Scale bars: 100 μm. The percentage of (I) proliferative and (J) apoptotic trophoblasts in DCN-untreated/treated cultures, calculated as the 
number of Ki67+ or cleaved cytokeratin-18+ cells into numbers of trophoblasts (K7+ cells). Results are presented as scatter plots with the indicated median 
values shown as horizontal lines. Statistical analyses between groups were performed using a nonparametric 2-tailed Mann-Whitney t test.
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NK cells are large granular lymphocytes of  the innate immune system and represent the first line of  
defense against pathogens (40). Unlike conventional NK cells found in the periphery, uNK cells are the 
dominant leukocyte population in the uterus in early pregnancy. In humans, uNK cell proportions greatly 
increase following ovulation and peak in number by 20 weeks of  gestation, after which uNK cell numbers 
gradually regress until term (16). Evidence from studies in mice suggest that uNK cells represent a distinct 
tissue-specific lineage derived from tissue-resident NK cell precursors (41). However, the influx or tissue-
homing potential of  peripheral NK cells into the uterus may also significantly contribute to uNK cell com-
position during pregnancy; this possibility is supported by adoptive bone marrow transfer experiments in 
mice showing that bone marrow-to-uterus homing of  NK cells is sufficient to rescue uterine arterial defects 
observed in NK cell–deficient mice (42). Our finding that CD56bright uNK cell numbers are decreased in the 
uterus of  obese women, in lieu of  proliferative regulation, indicates that either a defect in NK cell homing 
to the uterus exists, or that disruptions in NK cell lineage commitment or survival are taking place. Our 
finding that uNK cell survival is impaired in obesity while proliferation remains unaltered suggests that 
obesity-derived factors establish a potentially hostile environment towards uNK cells, limiting their longev-
ity. However, this interpretation requires some tempering, as Ki67 does not account for possible differences 
in cell cycle kinetics. Nonetheless, it will be important to phenotype peripheral blood NK cells as well as 
tissue residency markers of  uNK cells (i.e., CD9) in addition to activating and inhibiting NK cell recep-
tors (i.e., killer immunoglobulin-like receptors) to provide insight into obesity-directed functional changes 
in uNK cells. Future studies must also control for decidual sampling within the uterus (i.e., basalis versus 
parietalis), as possible spatial differences not controlled for in this study do require consideration. Interest-
ingly, peripheral NK cell tissue-homing defects were observed in pregnant diabetic women, indicating that 
a similar effect may also be taking place in the condition of  obesity (43).
Although unsupervised sample clustering using uNK cell global gene expression signatures did not 
distinguish between control or obese BMI groups, the use of  high-CV gene signatures across our samples 
did instruct sample segregation into control and obese groups with relatively high accuracy (75%). Incom-
plete sample segregation was somewhat expected as obesity itself  may well be a heterogeneous condi-
tion composed of  individuals having both healthy/unhealthy metabolism presenting without/with chronic 
inflammation (44). This latter point is crucial and is illustrated in our sample cohort in which obese women 
measuring healthy (low) serum CRP levels comprised 12% of  women in our cohort. In contrast, CRP-ele-
vated control/lean women made up just 7%, indicating that although low-grade inflammation and obesity 
are not directly linked with each other, a strong correlation still exists (i.e., over 75% of  obese women had 
elevated serum CRP). Moving forward, studies aimed at deciphering how obesity-related inflammation 
impacts immune cell function within the uterine environment in humans must consider adequate sample 
size number, and other variables likely contributing to heterogeneity such as ethnicity, lifestyle, age, and 
overall metabolic health.
Obesity-linked inflammation originating from adipose tissue is known to alter immune cell activity 
(9, 45). Therefore, we were surprised that minimal genes related to NK/immune cell function were dif-
ferentially expressed in the G1/G2 obese group. Although immune cell–specific genes (i.e., CD38, LIME1, 
NLRC3, LRMP, IL21R, and IL16) were shown to be underexpressed in the obese-enriched cohort, modest 
fold-change differences and pathway enrichment scores suggest that these alterations are not the major 
pathways instructing altered uNK cell biology. The finding that obesity led to enrichment of  transcrip-
tional programs related to growth factor binding and ECM organization was also unexpected. Notably, 
genes central to regulation of  placental function and uterine arterial remodeling were highly enriched in 
uNK cells from obese subjects, and included multiple IGFBPs (IGFBP-3, -4, -5, -6, and -7) and TIMPs 
(TIMP-1, -2, and -3). IGFBP-mediated sequestration of  IGF-I/II inhibits placental development by limit-
ing promitogenic and proinvasion signaling in trophoblasts (46, 47). Likewise, TIMP-directed inhibition of  
trophoblast- and uNK cell–derived metalloproteinases obstructs trophoblast invasion and MMP9-directed 
vascular remodeling (48). In both systems, defects in either IGF or MMP function are clinically linked to 
pregnancy disorders (49, 50). Our observation that decidual artery remodeling was impaired in obese wom-
en is consistent with the implications of  our transcriptional findings and establishes mechanistic insight as 
to why maternal obesity is associated with high-risk pregnancies.
Dynamic remodeling of  the ECM is essential for development, wound healing, and tissue homeosta-
sis, where chronic conditions arising from aberrant ECM deposition (i.e., fibrosis) lead to impairment in 
organ function. The increase in expression of  genes associated with fibrotic processes in the obese G1/
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G2 cluster is intriguing, as ECM composition influences immune cell behavior in inflamed tissues (51). 
For example, individual ECM proteins as well as complex three-dimensional ECM lattices convey specific 
information to immune cells to modulate cell infiltration into tissues, activation, and survival (36). Our 
finding that major gene pathways related to collagen production and organization are enriched in uNK 
cells from the obese G1/G2 group indicates that the uterine ECM is different in obese pregnancies com-
pared with that in lean pregnancies. Specifically, the overexpression of  multiple fibrillar collagens (COL1A1, 
COL1A2, COL3A1, COL4A5, COL5A1, COL5A2, COL6A1, COL6A2, and COL6A3) and collagen-modifying 
proteins (DCN) suggests that uNK cells in obesity are directly contributing to an altered uterine microenvi-
ronment. The overexpression of  PDGFRs that we have detected may be contributing to uNK cell–directed 
ECM production, but may also be playing a role in supporting uNK cell survival in a comparatively more 
hostile microenvironment. Localization of  collagen-I protein to uNK cells adjacent to unremodeled uter-
ine arteries supports previous work that highlights the role of  dysregulated ECM production in disrupted 
tissue-remodeling processes in cancer and chronic diseases (52). Exactly how ECM alterations affect uNK 
cell or other uterine immune cell function remains to be examined.
uNK cells produce factors that regulate trophoblast biology (53, 54). Our finding that the DCN gene 
is overexpressed in uNK cells from obese pregnancies identifies a potentially novel mechanism whereby 
maternal obesity negatively regulates placental development. Although uterine stromal-derived decorin has 
previously been shown to control trophoblast cell line invasion (34), our finding that decorin promotes 
apoptosis within distinct proliferative and invasive trophoblasts highlights a likely mechanism whereby 
decorin impedes placental development in vivo and establishes a potentially novel uNK cell–trophoblast 
interaction. Placental explants used in this study allow the interrogation of  complex cellular processes 
(i.e., formation of  proliferative trophoblast columns and differentiation of  proliferative trophoblasts into 
invasive extravillous cells) that are not possible to interrogate using cell line models, and therefore provide 
a realistic model to study early placentation.
uNK cells are distinct immune cell subsets that play fundamental roles in orchestrating healthy preg-
nancy. Conditions or environments that instruct deviations from normal uNK cell biology may contribute 
to impaired angiogenesis and placental establishment implicated in causing pregnancy disorders. Our study 
demonstrates a potential mechanistic link driven by maternal obesity in inhibiting uNK cell–directed blood 
vessel remodeling and trophoblast health. Furthermore, this work establishes insight into the downstream 
effects of  obesity-related chronic inflammation on uNK cell function in early pregnancy, thus highlighting 
a possible cellular effector contributing to obesity-driven poor pregnancy outcome. As obesity is an ever 
increasingly chronic condition in our population that poses serious consequences for reproductive health 
and fertility, understanding the cellular root causes affected by obesity is crucial. Investigation into how 
these obesity-related immunological changes within the uterus relate to pregnancy outcome will be of  
primary importance.
Methods
Patient recruitment and tissue collection. Blood, decidual, and placental tissues were obtained with approv-
al from the Research Ethics Board on the use of  human subjects, University of  British Columbia (H13-
00640). All samples were collected from women (19 to 35 years of  age) providing written informed con-
sent undergoing elective terminations of  pregnancy at British Columbia’s Women’s Hospital, Vancouver, 
Canada. First trimester decidual (n = 97) and placental tissues (n = 7), as well as whole-blood specimens 
(10 ml, n = 90) were collected from participating women (gestational ages ranging from 5 to 13 weeks) 
having confirmed viable pregnancies by ultrasound-measured fetal heartbeat. Decidual tissue samples were 
selected based on the presence of  a smooth uterine epithelial layer and a textured thick spongy underlayer. 
Serum was purified from whole blood using serum separator tubes following standard procedures. Patient 
clinical characteristics (i.e., height and weight) were additionally obtained to calculate BMI. All consenting 
women provided self-reported information via questionnaire regarding having diabetes, taking prescribed 
antiinflammatory or hypertensive medication, or having first-hand exposure to cigarette smoke. These self-
reported data are shown in Supplemental Table 1.
ELISA measurements of  serum CRP and leptin. Serum levels of  CRP and leptin were determined using 
commercial ELISA kits following the manufacturers’ protocols: Human High-Sensitivity (hs) CRP (Bio-
vendor) and Quantikine Human Leptin (R&D Systems). ELISA plates were read using a FLUOstar Opti-
ma plate reader (BMG LabTech). For hs-CRP and leptin measurements, serum was diluted 1:1,000 and 
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1:100. Samples were excluded for further downstream analyses if  serum CRP measurements exceeded 20 
μg/ml, as this level may be indicative of  an acute inflammatory response.
Decidual leukocyte isolation. Decidual tissues (n = 77) collected after elective termination of  pregnancy 
were washed extensively in ice-cold PBS (pH 7.4), after which the tissues were finely minced using sterile 
razor blades and subjected to enzymatic digestion. Briefly, decidual leukocyte enrichment was performed 
by digesting minced decidual homogenates for 1 hour at 37°C in 4 ml of  1:1 DMEM/F12 media (Gibco; 
200 mM L-glutamine) containing 1× collagenase/hyaluronidase (10× stock; StemCell Technologies), 80 
μg/ml DNase I (Sigma-Aldrich), penicillin/streptomycin (Life Technologies), and 100-fold-diluted Anti-
biotic-Antimycotic Solution (Life Technologies). After digestion, the cell/tissue suspension was vortexed 
for 30 seconds and washed 2 times in HBSS/2% FBS. Washed cells were sequentially pushed through 
70-μm and 40-μm cell strainers to obtain single-cell suspensions, followed by discontinuous Percoll density 
gradient centrifugation (layered 40%/80%); enriched decidual leukocytes (routinely > 90% CD45+ cells as 
assayed by flow cytometry) were collected from the middle cell layer located between the 40% and 80% Per-
coll. Decidual leukocytes were either (a) immediately used to isolate uterine NK cells for RNA extraction 
or short-term cell culture experiments, (b) stored in freezing media (90% FBS + 10% DMSO) to be used for 
downstream cell surface marker characterization via flow cytometry, or (c) subjected to cytokine expres-
sion, cytotoxicity, or migration experiments. Decidual NK cells were enriched via a combined negative 
selection and positive exclusion strategy using two customized immunolabeled magnetic bead cocktails fol-
lowing the manufacturer’s protocol (formulated on the EasySep Human NK cell Enrichment Kit platform; 
StemCell Technology). The negative depletion antibody cocktail containing beads conjugated to antibodies 
directed against CD3, CD4, CD14, CD19, CD20, CD36, CD66b, CD123, and CD31 removed non-NK cell 
leukocytes and contaminating endothelial cells, leaving the remaining NK cell fraction “untouched.” This 
NK-enriched fraction was next subjected to CD16 positive exclusion (EasySep Kit, StemCell Technologies) 
to remove CD56+CD16+ NK cells. CD56bright cell purity was routinely greater than 95% as assayed by flow 
cytometry (Figure 2A). For experiments performed in Figures 6 and 7, uNK cell isolation was performed 
using only negative selection directly followed by a 2-hour preculture in complete RPMI media to remove 
contaminating stromal cells.
Flow cytometric analysis of  extracellular markers. Following washing in FACS buffer (1× HBSS, 2% FBS), 
2 × 105 decidual leukocytes (per multicolor stain) were blocked with human FcR binding inhibitor (eBio-
science) and incubated with the following extracellular markers: CD45-PerCP-eFluor 710 (1:100; clone 
HI30), CD56-FITC (1:25; clone MEM188), CD3-APC-eFluor 780 (1:100; clone SK7), CD16-APC (1:50; 
clone CB16), Fixable Viability Dye eFluor 780 (1:1,000; all from eBioscience) for 30 minutes at 4°C. The 
cells were then fixed and permeabilized with fixation and permeabilization reagents from eBioscience, 
used according to the guidelines from the manufacturer. Afterwards, the cells were stained with Ki67-PE-
Cy7 (1:20; clone 20Raj1; eBioscience) for another 30 minutes at 4°C. In a separate batch of  experiments, 
decidual leukocytes were labeled with the following markers: CD45-PerCP-eFluor 710 (1:100), CD56-eFlu-
or 450 (1:100; clone TULY56), CD3-APC-eFluor 780 (1:100), CD16-APC (1:50), Fixable Viability Dye 
eFluor 780 (1:1,000; all from eBioscience), PDGFR-β/CD140b-PE (1:20; clone REA363; Miltenyi Biotec), 
and CD9-FITC (1:25; clone M-L13; BD Biosciences) for 30 minutes at 4°C. Following staining, cells were 
resuspended in PBS and data were collected on the BD FACS Fortessa flow cytometer (BD Biosciences) 
and analyzed using FlowJo software (Tree Star Inc.).
Intracellular cytokine analysis, NK cell cytotoxicity assay, and PDGF-BB stimulation. Following washing in 
FACS buffer (1× HBSS, 2% FBS), 1 × 106 decidual leukocytes were resuspended in RPMI supplemented 
with 10% FBS, 100 U/ml penicillin, and 100 mg/ml streptomycin, and cocultured with K562 cells at an 
effector:target ratio of  2:1 for 5 hours at 37°C. Cells cultured in complete RPMI medium served as a nega-
tive control, whereas stimulation with 10 ng/ml phorbol 12-myristate 13-acetate (PMA) and 500 ng/ml 
ionomycin served as a positive control. In a subset of  experiments, decidual leukocytes were treated with 
30 ng/ml recombinant human PDGF-BB (R&D Systems); all cells were cultured in the presence of  3 μg/
ml brefeldin A and 2 μM monensin (eBioscience), as well as with CD107a-PE (1:200; clone eBioH4A3; 
BD Biosciences). After incubation, decidual leukocytes were blocked with human FcR binding inhibitor 
(eBioscience) and labeled with antibodies directed against extracellular markers: CD45-PerCP-eFluor 710 
(1:100; clone HI30), CD56-FITC (1:25; clone MEM188), CD3-APC-eFluor 780 (1:100), Fixable Viability 
Dye eFluor 780 (1:1,000; eBioscience), and CD107a-PE (1:20; BD Biosciences) for 30 minutes at 4°C. 
Cells were then fixed and permeabilized with Fixation/Permeabilization Buffer (eBioscience). Afterwards, 
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cells were stained with TNF-α-APC (1:20; clone MAb11) and IFN-γ-AF700 (1:50; clone 4S.B3) for an 
additional 30 minutes at 4°C (both antibodies from eBioscience). Cells were resuspended in PBS and data 
were collected on the BD FACS Fortessa flow cytometer and analyzed using FlowJo software. For PDGFR 
pathway analysis, 1 × 106 negatively selected (StemSep; Stem Cell Technology) uNK cells were preplated 
for 2 hours in RPMI to remove contaminating fibroblasts, harvested, and starved in RPMI media for 5 
hours at 37°C and 5% CO2. Following starvation, uNK cells were stimulated with 100 ng/ml PDGF-BB 
for 10 minutes at 37°C, placed on ice, centrifuged at 4°C, and lysed in RIPA protein extraction buffer (20 
mM Tris-HCl, pH 7.6, 1% Triton X-100, 0.1% SDS, 1% NP-40, 1% sodium deoxycholate, 5 mM EDTA, 
50 mM NaCl). For examining the effects of  PDGF-BB on gene expression, 1 × 106 uNK cells were treated 
with 30 ng/ml PDGF-BB in RPMI medium containing 1% FBS, 5 ng/ml IL-15 (BioLegend), 55 nM 2-ME, 
1 mM sodium pyruvate (Life Technologies), penicillin/streptomycin (Life Technologies), and Antibiotic-
Antimycotic Solution (Life Technologies) for 12 hours at 37°C and 5% CO2.
Decidual NK cell migration assay. Decidual NK cell migration was assayed using 5.0-μm-pore Boyden 
chamber Transwell inserts fitted into in 24-well plates (Corning). Decidual leukocytes (2 × 105 cells) in 100 
μl of  serum-free media were added to the top insert chamber; inserts were placed into 24-well plates con-
taining 600 μL of  RPMI 1640 media either (a) supplemented with 10% FBS, (b) supplemented with 30 ng/
ml of  PDGF-BB, or (c) serum-free media alone. Assays were performed at 37°C and 5% CO2 for 3 hours. 
Afterwards, cells that passed through the filter were collected and stained with the indicated antibodies: 
CD45 (PerCP-eFluor 710; clone HI30), CD3 (PE-Cy7; clone UCHT1), CD56 (FITC; clone MEM188), 
CD16 (APC; clone CB16), and Fixable Viability Dye eFluor 780 (eBioscience). Absolute cell counting was 
determined with an internal control (123count eBeads; eBioscience) following the manufacturer’s protocol 
using the BD Fortessa flow cytometer.
RNA purification and microarray expression analysis. Total RNA was prepared from immunomagnetic 
bead–enriched uNK cells using the RNAqueous Total RNA Isolation Kit following the manufacturer’s 
instructions (Ambion). RNA purity was confirmed using a NanoDrop Spectrophotometer (Thermo Fish-
er Scientific) and by running RNA samples on an Agilent 2100 Bioanalyzer (Agilent Technologies). For 
microarray analysis, only RNA samples having an RNA integrity number (RIN) greater than 7.0 were used. 
For microarray gene expression analysis, 24 biotin-labeled cRNA samples were generated using Targe-
tAmp labeling kits (13 control and 11 obese uNK cell samples) and were hybridized onto HumanHT-12 v4 
Expression BeadChips (Illumina). The HumanHT-12 v4 Expression BeadChips target greater than 47,000 
probes derived from the NCBI RefSeq Release 38 (November 7, 2009).
Data preprocessing and identification of  signature genes and pathways. Preprocessing and statistical analyses 
of  raw Illumina IDAT files were performed within the R statistical environment (v2.15.2) using the limma 
library beadarray (v3.14.3) (55, 56) packages of  the Bioconductor open-source project (57). Raw expression 
data were log transformed and quantile normalized using the normaliseIllumina() function. The probe-
wise quality grade was estimated by the illuminaHumanv4PROBEQUALITY() function for 48,107 probes 
in the raw microarray data, resulting in 34,476 high-quality probes (quality grade “Good” or “Perfect”) for 
the following analysis, after removing 13,631 poor-quality probes (grade “Bad”) and probes that could not 
be mapped to any genes (labeled as “No match”). Batch effect was corrected using the surrogate variable 
analysis SVA () function. PCA and surrogate variable analysis were performed by the built-in svd() func-
tion and the sva package in R. After preprocessing, mRNA expression was analyzed using the univariate 
linear model. All model-based t tests were corrected using empirical Bayes moderation of  the SE, followed 
by FDR adjustment for multiple testing (58). Genes that showed significant differential expression were 
filtered based on a q value less than 0.001. Enrichment of  pathways in high-CV genes or genes that were 
shown to be differentially expressed between G1/2 and G3/4 clusters were identified and annotated using 
ToppGene software (31). Processed data were plotted using gplots and ape bioconductor packages in R.
qPCR analysis. One microgram of  RNA was reverse-transcribed using a first-strand cDNA syn-
thesis kit (QuantaBiosciences Inc.) and analyzed by qPCR (ΔΔCT), using Perfecta SYBR Green 
FastMix (QuantaBiosciences) on an ABI 7500 Sequence Detection System (Life Technologies). For-
ward and reverse primer sets were as follows: PDGFRA (F: 5′-TTCCTCTGCCTGACATTGAC-3′, 
R: 5′-GTCTTCAATGGTCTCGTCCTC-3′); PDGFRB (F: 5′-CCACACTCCTTGCCCTTTAAG-3′, 
R: 5′-CTCACAGACTCAATCACCTTCC-3′); COL1A1 (F: 5′-TACAGCGTCACTGTCGATGG-3′, 
R: 5′-TCAATCACTGTCTTGCCCCAG-3′); COL3A1 (F: 5′-AAGTCAAGGAGAAAGTGGTCG-3′, 
R: 5′-CTCGTTCTCCATTCTTACCAGG-3′); COL6A3 (F: 5′-GAGATGTTGGGATTCGAGGG-3′, 
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R: 5′-GTTTCTCCTTTGGGTCCTCTC-3′); DCN (F: 5′-TGATGCAGCTAGCCTGAAAGG-3′, 
R: 5′-AGGCGTGTTGGCCAGAGAG-3′); GAPDH (F: 5′-AGGGCTGCTTTTAACTCTGGT -3′, 
R: 5′-CCCCACTTGATTTTGGAGGGA -3′). All raw data were analyzed using Sequence Detection Sys-
tem software version 2.1 (Life Technologies). The threshold cycle (CT) values were used to calculate rela-
tive RNA expression levels. Values were normalized to endogenous GAPDH transcripts.
Immunohistochemistry and IF microscopy. Uterine decidual specimens (11–13 weeks of  gestation; n = 20) 
and Matrigel-imbedded placental explants (5–8 weeks of  gestation, n = 28) were fixed in 2% paraformal-
dehyde overnight at 4°C. Tissues and explants were paraffin embedded and serially sectioned at 5 μm onto 
glass slides. IF was performed as described previously (59). Briefly, tissues underwent antigen retrieval by 
heating slides in a microwave for five 2-minute intervals in citrate buffer (pH 6.0). Sections were incubated 
with sodium borohydride for 5 minutes at room temperature, followed by 0.1% Triton X-100 permeabiliza-
tion for 5 minutes at room temperature. Slides were blocked in 5% normal goat serum/0.1% saponin for 
1 hour at room temperature, and incubated with combinations of  the indicated antibodies overnight at 
4°C: mouse monoclonal CD56 (1:200; clone 123C3; Cell Signaling Technology); rabbit monoclonal CD56 
(1:100; clone EP2567Y; Abcam); mouse monoclonal SMA (1:400; clone 1A4; Dako); mouse monoclo-
nal CD31 (1:400; clone JC70A; Dako); rabbit polyclonal PDGFR-α (1:200; Upstate); rabbit monoclonal 
keratin-7 (1:75; clone SP52; Ventana); mouse monoclonal keratin-7 (1:200; clone C46; Santa Cruz Bio-
technology); rabbit monoclonal Ki67 (1:100; clone SP6; Thermo Fisher Scientific); mouse monoclonal 
caspase-cleaved keratin-18 (1:25; clone M30; Roche); rabbit monoclonal cleaved caspase-3 (1:200; clone 
5A1E; Cell Signaling Technology); and mouse monoclonal decorin (1:100; Ab54728; Abcam). Slides were 
incubated with Alexa Fluor 568/488–conjugated goat anti-rabbit and goat anti-mouse secondary antibod-
ies (Life Technologies) for 1 hour at room temperature. Glass coverslips were mounted onto slides using 
DAPI mounting media (Life Technologies) and slides were imaged using a 20× Plan-Apochromat/0.80 
NA or 40× Plan-Apochromat oil/1.4 NA objective (Carl Zeiss). An ApoTome.2 structured illumination 
device (Carl Zeiss) set at full Z-stack mode and 5 phase images was used in imaging Figures 2I and 6C. For 
quantification of  uNK cell numbers, artery smooth muscle thickness, vessel:lumen ratio, arteries per field 
of  view, proportion of  cleaved caspase-3 CD56+ cells and mean decorin channel intensity, 10 images per tis-
sue section (obtained using a 20× objective) were used to calculate values. uNK cell quantities were calcu-
lated by CD56+/DAPI+ cells per field of  view averaged over 10 images. CD56 and cleaved caspase-3 signal 
hierarchical thresholding, based on DAPI+ cells meeting CD56 and cleaved caspase-3 fluorescence intensity 
thresholds, was used to calculate CD56+ and CD56+/cleaved caspase-3+ proportions. Smooth muscle (SM) 
artery thickness was calculated by averaging 8 linear measurements (μm) of  SM artery signal that encap-
sulated an artery (from outermost SM artery signal to SM artery signal proximal to inner arterial lumen); 
vessel:lumen ratios were calculated by dividing the SM artery area (μm2) surrounding an artery into the 
artery lumen area (μm2). Mean decorin signal was measured using raw EGFP channel fluorescence inten-
sity readings using a circular drawing tool to isolate and quantify decorin signal in and within 5 μm of  uNK 
cells (defined by CD56 signal); 200 uNK cells per sample were quantified. Images were obtained using an 
Axiocam 506 monochrome digital camera and processed and analyzed using ZenPro software (Carl Zeiss).
Cell lysis and immunoblot analysis. Cells were washed in ice-cold PBS and incubated in RIPA cell extrac-
tion buffer supplemented with 10 mM Na3VO4, 10 mM NaF, 2 mM PMSF, and an appropriate dilution of  
Complete Mini, EDTA-free protease inhibition cocktail tablets (Roche). Protein concentrations were deter-
mined using a BCA kit (Thermo Fisher Scientific). For immunoblotting, 30 μg of  cell protein lysate or con-
ditioned media was resolved by SDS-PAGE and transferred to nitrocellulose membranes. The membranes 
were probed using monoclonal antibodies directed against phosphorylated p44/42 MAPK (p-Erk1/2, 
Thr202/Tyr204), p44/42 MAPK (Erk1/2), phosphorylated Akt/PKB (p-Akt, Ser473), Akt, phosphory-
lated PDGFR-α/β (p-PDGFR-α/β, Tyr 849/857) (all from Cell Signaling Technology), PDGFR-α (clone 
C-20; Santa Cruz Biotechnology), and a goat polyclonal antibody targeting decorin (AF143; R&D Sys-
tems). The blots were stripped and reprobed with an HRP-conjugated monoclonal antibody directed 
against mouse β-actin (Santa Cruz Biotechnology).
Placental villous explant assay. Ex vivo placental villous cultures were established as previously described 
(59). Briefly, placental villi from placentae (n = 7) at 5 to 8 weeks of  gestation obtained from patients 
undergoing elective termination of  pregnancy were dissected, washed in cold PBS, and imbedded in Mil-
licell cell culture inserts (0.4-μm pores, 12-mm diameter; EMD Millipore) containing 200 μl of  Growth 
Factor–Reduced, Phenol Red–Free Matrigel (BD Biosciences). Explants, containing 400 μl DMEM/
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F12 1:1 (200 mM L-glutamine) in the outer chamber, were allowed to establish overnight in a humidified 
37°C trigas incubator at 3% oxygen, 5% CO2. Concurrent with explant establishment, negatively selected 
uNK cells from the same tissue sample were cultured for 18 hours in RMPI containing 1% FBS, 5 ng/ml 
IL-15 (BioLegend), 55 nM 2-ME, 1 mM sodium pyruvate (Life Technologies), penicillin/streptomycin 
(Life Technologies) and Antibiotic-Antimycotic (diluted 100-fold). Following culture, uNK cell CM (and 
complete RPMI media as negative control) was collected, centrifuged, and concentrated 10-fold in 10-kDa 
concentrating filters (Millipore). Following 24 hours of  culture, explants were cultured in 200 μl DMEM/
F12 1:1 media containing: (a) uNK cell CM (diluted 1/10); (b) RPMI media containing 1% FBS, 5 ng/
ml IL-15, and 55 nM 2-ME; (c) 20 μg/ml recombinant human decorin (ab169898; Abcam); or (d) media 
alone for an additional 48 hours. Endogenous decorin in uNK CM was functionally blocked using 10 μg/
ml anti-decorin neutralizing antibody (AF143; R&D Systems); uNK CM was pretreated for 1 hour at 37°C 
with anti-decorin antibody prior to explant culture. All explant media were supplemented with penicillin/
streptomycin and Antibiotic-Antimycotic Solution. Growing explants were imaged at indicated times using 
a Nikon SMZ 7454T triocular dissecting microscope outfitted with a digital camera. Extravillous tropho-
blast (EVT) outgrowths were measured by ImageJ software (NIH). Length of  outgrowths was determined 
by dividing the mean column length (5 measurements per explant) at 48 hours into the mean column length 
at 0 hours. Each treatment was conducted in duplicate and each experiment was performed 3 or 4 times 
using 7 different placentae.
Statistics. Flow cytometry, microscopy image quantification, and cell migration data are reported as 
median values and IQRs. qPCR gene expression data are presented as mean values ± standard deviation. 
All calculations were carried out using GraphPad Prism software. For single comparisons, either Mann-
Whitney nonparametric unpaired 2-tailed t tests or 2-tailed Wilcoxon signed-rank t tests (Figure 6) were 
performed. The differences were accepted as significant at P less than 0.05. For microarray gene expression 
statistical analyses, please refer to the Data Preprocessing section in methods.
Study approval. The present study in humans was reviewed and approved by the Research Ethics Board 
on the use of  human subjects, University of  British Columbia, Vancouver, British Columbia, Canada 
(human ethics certificate number H13-00640).
Accession number. The GEO accession number for the data reported in this paper is GSE75091.
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